Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
Renal failure is far too expensive in cost and mortality for every country as well as every patient. It makes work impossible, and average life expectancy is in single digits. Discussing dialysis when a safe, efficient method exists to prevent it is bad public health. Nobody pushed iron lungs after Jonas Salk's vaccine showed promise. Please see my earlier BMJ Rapid Response for how to prevent most dialysis (https://www.bmj.com/content/363/bmj.k4303/rr). I envision a world in which the 10% of ESRD patients remaining after a global effort to prevent dialysis could all get a cadaver kidney transplant with a minimum of dialysis time.
Both of my protocols, for acute and chronic renal failure, are now in the public domain. As the Founder and CEO of GenoMed, Inc. (www.genomed.com), I am delighted to consult with any patient or group that would like to avoid dialysis.